Skip to main content

Advertisement

Log in

Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

A 38-year-old woman had noticed sclerodactylia and Raynaud’s phenomenon 10 months before consultation. She was diagnosed as having systemic sclerosis (SSc) based on the skin sclerosis of her arms, chest, and face. Antinuclear antibody (ANA) level was 1:1280 with a speckled pattern, but specific autoantibodies were negative. Following the treatment with oral prednisolone and D-penicillamine, her skin sclerosis gradually improved. Three months after initiation of prednisolone, she presented Pneumocystis carinii pneumonia. About 1 year after the first admission, the pattern of indirect immunofluorescence staining changed from the speckled pattern to the discrete speckled pattern, and simultaneously anticentromere antibody (ACA) was detected by enzyme-linked immunosorbent assay. Her skin sclerosis rapidly and remarkably improved after appearance of ACA. It is generally considered that once certain SSc-specific autoantibody occurs, it does not disappear and change into other specificity of autoantibody thereafter. This case suggests that the presence of ACA closely correlates with clinical features and also suggests that clinical features may change during the clinical course with the appearance of another specific ANA. This case is very rare because such a case was not reported previously.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1 a, b
Fig. 2

Similar content being viewed by others

References

  1. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C (1980) Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23:617–625

    CAS  PubMed  Google Scholar 

  2. LeRoy EC, Krieg T, Black C, Medsger TAJ, Fleischmajer R, Rowell N, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15:202–205

    CAS  PubMed  Google Scholar 

  3. Steen VD, Powell DL, Medsger TAJ (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203

    CAS  PubMed  Google Scholar 

  4. Igarashi A, Takehara K, Soma Y, Kikuchi K, Ishibashi Y (1990) Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis. Dermatologica 180:136–140

    CAS  PubMed  Google Scholar 

  5. Steen VD, Medsger TA, Jr., Rodnan GP (1982) D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med 97:652–659

    Google Scholar 

  6. Medsger TA, Steen VD (1996) Classification, prognosis. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams & Wilkins, Baltimore, pp 51–64

  7. Chechani V, Bridges A (1992) Pneumocystis carinii pneumonia in patients with connective tissue disease. Chest 101:375–378

    CAS  PubMed  Google Scholar 

  8. Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789

    Article  CAS  PubMed  Google Scholar 

  9. Hamamdzic D, Kasman LM, LeRoy EC (2002) The role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 14:694–698

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinichi Sato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayakawa, I., Sato, S., Echigo, T. et al. Improvement of skin sclerosis after occurrence of anticentromere antibody in a patient with diffuse cutaneous systemic sclerosis. Clin Rheumatol 23, 345–347 (2004). https://doi.org/10.1007/s10067-004-0876-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-0876-9

Keywords

Navigation